nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—OPRK1—Progesterone—uterine cancer	0.297	0.303	CbGbCtD
Ketobemidone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.129	0.131	CbGbCtD
Ketobemidone—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0897	0.0913	CbGbCtD
Ketobemidone—CYP2C8—Progesterone—uterine cancer	0.0852	0.0867	CbGbCtD
Ketobemidone—CYP2C19—Progesterone—uterine cancer	0.0715	0.0727	CbGbCtD
Ketobemidone—PTGS1—Etoposide—uterine cancer	0.0661	0.0672	CbGbCtD
Ketobemidone—CYP2C9—Progesterone—uterine cancer	0.0594	0.0604	CbGbCtD
Ketobemidone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0522	0.0531	CbGbCtD
Ketobemidone—CYP2C8—Etoposide—uterine cancer	0.0381	0.0388	CbGbCtD
Ketobemidone—CYP3A4—Progesterone—uterine cancer	0.0346	0.0351	CbGbCtD
Ketobemidone—CYP2B6—Doxorubicin—uterine cancer	0.0343	0.0349	CbGbCtD
Ketobemidone—CYP3A4—Etoposide—uterine cancer	0.0155	0.0157	CbGbCtD
Ketobemidone—CYP3A4—Doxorubicin—uterine cancer	0.0105	0.0107	CbGbCtD
Ketobemidone—PTGS1—oviduct—uterine cancer	0.000883	0.118	CbGeAlD
Ketobemidone—UGT1A9—renal system—uterine cancer	0.000782	0.104	CbGeAlD
Ketobemidone—OPRD1—renal system—uterine cancer	0.000618	0.0825	CbGeAlD
Ketobemidone—PTGS1—artery—uterine cancer	0.000585	0.078	CbGeAlD
Ketobemidone—OPRK1—female reproductive system—uterine cancer	0.000475	0.0633	CbGeAlD
Ketobemidone—CYP2C8—renal system—uterine cancer	0.000254	0.0338	CbGeAlD
Ketobemidone—CYP2C8—endometrium—uterine cancer	0.000245	0.0327	CbGeAlD
Ketobemidone—CYP2B6—renal system—uterine cancer	0.000227	0.0303	CbGeAlD
Ketobemidone—PTGS1—epithelium—uterine cancer	0.000222	0.0296	CbGeAlD
Ketobemidone—PTGS1—uterine cervix—uterine cancer	0.00022	0.0293	CbGeAlD
Ketobemidone—PTGS1—smooth muscle tissue—uterine cancer	0.000214	0.0285	CbGeAlD
Ketobemidone—CYP2C19—vagina—uterine cancer	0.00021	0.0281	CbGeAlD
Ketobemidone—PTGS1—renal system—uterine cancer	0.000206	0.0274	CbGeAlD
Ketobemidone—CYP2C8—female reproductive system—uterine cancer	0.000203	0.0271	CbGeAlD
Ketobemidone—PTGS1—endometrium—uterine cancer	0.000199	0.0265	CbGeAlD
Ketobemidone—PTGS1—mammalian vulva—uterine cancer	0.000192	0.0257	CbGeAlD
Ketobemidone—CYP2C8—vagina—uterine cancer	0.000184	0.0245	CbGeAlD
Ketobemidone—PTGS1—uterus—uterine cancer	0.000183	0.0244	CbGeAlD
Ketobemidone—CYP2B6—female reproductive system—uterine cancer	0.000182	0.0243	CbGeAlD
Ketobemidone—CYP2C9—female reproductive system—uterine cancer	0.00018	0.0241	CbGeAlD
Ketobemidone—CYP3A4—renal system—uterine cancer	0.000172	0.0229	CbGeAlD
Ketobemidone—CYP2B6—vagina—uterine cancer	0.000165	0.022	CbGeAlD
Ketobemidone—PTGS1—female reproductive system—uterine cancer	0.000165	0.022	CbGeAlD
Ketobemidone—PTGS1—female gonad—uterine cancer	0.00015	0.02	CbGeAlD
Ketobemidone—PTGS1—vagina—uterine cancer	0.000149	0.0199	CbGeAlD
Ketobemidone—CYP3A4—female reproductive system—uterine cancer	0.000138	0.0184	CbGeAlD
Ketobemidone—PTGS1—lymph node—uterine cancer	9.63e-05	0.0129	CbGeAlD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.35e-05	0.00148	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CXCL8—uterine cancer	1.3e-05	0.00142	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.0014	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RNF43—uterine cancer	1.27e-05	0.00139	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NDUFB11—uterine cancer	1.27e-05	0.00139	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SRD5A2—uterine cancer	1.27e-05	0.00139	CbGpPWpGaD
Ketobemidone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.27e-05	0.00139	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	1.27e-05	0.00139	CbGpPWpGaD
Ketobemidone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.25e-05	0.00137	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKR1C1—uterine cancer	1.24e-05	0.00136	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.24e-05	0.00135	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.23e-05	0.00135	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CCL2—uterine cancer	1.22e-05	0.00133	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.17e-05	0.00128	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—INHBA—uterine cancer	1.16e-05	0.00127	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—RRM2—uterine cancer	1.14e-05	0.00125	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CXCL8—uterine cancer	1.14e-05	0.00125	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.00124	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.00124	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—POLD1—uterine cancer	1.12e-05	0.00122	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—DCN—uterine cancer	1.11e-05	0.00121	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.1e-05	0.00121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKR1C3—uterine cancer	1.09e-05	0.00119	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.09e-05	0.00119	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—STAR—uterine cancer	1.09e-05	0.00119	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PGR—uterine cancer	1.06e-05	0.00116	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKR1C1—uterine cancer	1.05e-05	0.00115	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKR1C1—uterine cancer	1.05e-05	0.00114	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP11A1—uterine cancer	1.05e-05	0.00114	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.04e-05	0.00114	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.04e-05	0.00113	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.04e-05	0.00113	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—YWHAE—uterine cancer	1.01e-05	0.00111	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.01e-05	0.0011	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKR1C3—uterine cancer	9.87e-06	0.00108	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—FBXW7—uterine cancer	9.7e-06	0.00106	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CXCL8—uterine cancer	9.64e-06	0.00106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKR1C3—uterine cancer	9.55e-06	0.00105	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.5e-06	0.00104	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—RRM2—uterine cancer	9.31e-06	0.00102	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PGR—uterine cancer	9.3e-06	0.00102	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—STAR—uterine cancer	9.2e-06	0.00101	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKR1B1—uterine cancer	9.2e-06	0.00101	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.09e-06	0.000995	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—DCN—uterine cancer	9.04e-06	0.00099	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—YWHAE—uterine cancer	8.88e-06	0.000972	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—POLD1—uterine cancer	8.52e-06	0.000933	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP11A1—uterine cancer	8.52e-06	0.000932	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FBXW7—uterine cancer	8.51e-06	0.000931	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—STK11—uterine cancer	8.48e-06	0.000928	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CCL2—uterine cancer	8.44e-06	0.000924	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—STAR—uterine cancer	8.21e-06	0.000898	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKR1B1—uterine cancer	8.21e-06	0.000898	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.11e-06	0.000888	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKR1C3—uterine cancer	8.07e-06	0.000883	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKR1C3—uterine cancer	8.04e-06	0.000881	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKR1C1—uterine cancer	7.97e-06	0.000873	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SOCS3—uterine cancer	7.94e-06	0.000869	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PGR—uterine cancer	7.86e-06	0.000861	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—STK11—uterine cancer	7.69e-06	0.000842	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP19A1—uterine cancer	7.69e-06	0.000842	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN2B—uterine cancer	7.6e-06	0.000832	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—YWHAE—uterine cancer	7.5e-06	0.000821	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—STAR—uterine cancer	7.48e-06	0.000819	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKR1B1—uterine cancer	7.48e-06	0.000819	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—STK11—uterine cancer	7.44e-06	0.000814	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CCL2—uterine cancer	7.4e-06	0.00081	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.4e-06	0.00081	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IGF1R—uterine cancer	7.38e-06	0.000808	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCL8—uterine cancer	7.35e-06	0.000805	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.22e-06	0.00079	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—POLD1—uterine cancer	7.22e-06	0.00079	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FBXW7—uterine cancer	7.19e-06	0.000787	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—RRM2—uterine cancer	7.11e-06	0.000778	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SOCS3—uterine cancer	6.97e-06	0.000762	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SMAD3—uterine cancer	6.94e-06	0.00076	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—DCN—uterine cancer	6.9e-06	0.000755	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.88e-06	0.000753	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.83e-06	0.000747	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.83e-06	0.000747	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKR1C1—uterine cancer	6.75e-06	0.000739	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCL8—uterine cancer	6.68e-06	0.000731	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN2B—uterine cancer	6.67e-06	0.00073	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—FGFR2—uterine cancer	6.62e-06	0.000725	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP11A1—uterine cancer	6.5e-06	0.000711	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1R—uterine cancer	6.48e-06	0.000709	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCL8—uterine cancer	6.45e-06	0.000706	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—POLD1—uterine cancer	6.44e-06	0.000705	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—STK11—uterine cancer	6.29e-06	0.000688	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP19A1—uterine cancer	6.27e-06	0.000686	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—STK11—uterine cancer	6.27e-06	0.000686	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CCL2—uterine cancer	6.26e-06	0.000685	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKR1C3—uterine cancer	6.14e-06	0.000672	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SMAD3—uterine cancer	6.09e-06	0.000666	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKR1C1—uterine cancer	6.03e-06	0.000659	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—RRM2—uterine cancer	6.02e-06	0.000659	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SOCS3—uterine cancer	5.89e-06	0.000644	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.88e-06	0.000644	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—POLD1—uterine cancer	5.87e-06	0.000643	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL8—uterine cancer	5.85e-06	0.000641	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—DCN—uterine cancer	5.84e-06	0.000639	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FGFR2—uterine cancer	5.81e-06	0.000636	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—MTHFR—uterine cancer	5.78e-06	0.000632	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ESR1—uterine cancer	5.67e-06	0.00062	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN2B—uterine cancer	5.64e-06	0.000617	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.61e-06	0.000614	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP11A1—uterine cancer	5.5e-06	0.000602	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKR1C1—uterine cancer	5.49e-06	0.000601	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1R—uterine cancer	5.47e-06	0.000599	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL8—uterine cancer	5.45e-06	0.000596	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—RRM2—uterine cancer	5.37e-06	0.000588	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—NRAS—uterine cancer	5.36e-06	0.000586	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—DCN—uterine cancer	5.21e-06	0.000571	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKR1C3—uterine cancer	5.2e-06	0.000569	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SMAD3—uterine cancer	5.15e-06	0.000563	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.09e-06	0.000557	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCL2—uterine cancer	4.99e-06	0.000546	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ESR1—uterine cancer	4.97e-06	0.000544	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL8—uterine cancer	4.95e-06	0.000542	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—STAR—uterine cancer	4.94e-06	0.00054	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.94e-06	0.00054	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP11A1—uterine cancer	4.91e-06	0.000538	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FGFR2—uterine cancer	4.91e-06	0.000537	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—RRM2—uterine cancer	4.9e-06	0.000536	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP19A1—uterine cancer	4.78e-06	0.000523	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—STK11—uterine cancer	4.78e-06	0.000523	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—DCN—uterine cancer	4.75e-06	0.00052	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—MTHFR—uterine cancer	4.71e-06	0.000516	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—NRAS—uterine cancer	4.7e-06	0.000514	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—uterine cancer	4.66e-06	0.00051	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKR1C3—uterine cancer	4.64e-06	0.000508	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—KRAS—uterine cancer	4.61e-06	0.000505	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP11A1—uterine cancer	4.48e-06	0.00049	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL2—uterine cancer	4.37e-06	0.000479	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—uterine cancer	4.23e-06	0.000464	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKR1C3—uterine cancer	4.23e-06	0.000463	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ESR1—uterine cancer	4.2e-06	0.00046	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—uterine cancer	4.16e-06	0.000455	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.15e-06	0.000454	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—uterine cancer	4.09e-06	0.000448	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP19A1—uterine cancer	4.05e-06	0.000443	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—STK11—uterine cancer	4.05e-06	0.000443	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—KRAS—uterine cancer	4.04e-06	0.000442	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—NRAS—uterine cancer	3.97e-06	0.000434	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL8—uterine cancer	3.94e-06	0.000432	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—HRAS—uterine cancer	3.92e-06	0.000429	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—POLD1—uterine cancer	3.87e-06	0.000424	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1B—uterine cancer	3.85e-06	0.000422	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—uterine cancer	3.81e-06	0.000417	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.8e-06	0.000416	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—uterine cancer	3.71e-06	0.000406	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL2—uterine cancer	3.7e-06	0.000405	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—uterine cancer	3.65e-06	0.000399	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CTNNB1—uterine cancer	3.64e-06	0.000398	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.62e-06	0.000397	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.62e-06	0.000397	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—STK11—uterine cancer	3.61e-06	0.000396	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.61e-06	0.000396	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—uterine cancer	3.59e-06	0.000393	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PTEN—uterine cancer	3.55e-06	0.000388	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—uterine cancer	3.46e-06	0.000379	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL8—uterine cancer	3.46e-06	0.000379	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—uterine cancer	3.46e-06	0.000378	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—HRAS—uterine cancer	3.44e-06	0.000376	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—KRAS—uterine cancer	3.42e-06	0.000374	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.39e-06	0.000371	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EP300—uterine cancer	3.38e-06	0.00037	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1B—uterine cancer	3.38e-06	0.00037	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—uterine cancer	3.34e-06	0.000366	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.29e-06	0.000361	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—STK11—uterine cancer	3.29e-06	0.000361	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.23e-06	0.000354	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—RRM2—uterine cancer	3.23e-06	0.000353	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTEN—uterine cancer	3.21e-06	0.000352	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—uterine cancer	3.2e-06	0.000351	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CTNNB1—uterine cancer	3.19e-06	0.000349	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NRAS—uterine cancer	3.16e-06	0.000346	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—uterine cancer	3.14e-06	0.000344	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—DCN—uterine cancer	3.13e-06	0.000343	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PTEN—uterine cancer	3.11e-06	0.00034	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.09e-06	0.000339	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—uterine cancer	3.08e-06	0.000337	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—EP300—uterine cancer	3.07e-06	0.000335	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—uterine cancer	3.04e-06	0.000333	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—uterine cancer	3.03e-06	0.000332	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EP300—uterine cancer	2.97e-06	0.000325	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.95e-06	0.000323	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.95e-06	0.000323	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL8—uterine cancer	2.92e-06	0.00032	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—HRAS—uterine cancer	2.9e-06	0.000318	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1B—uterine cancer	2.85e-06	0.000312	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—uterine cancer	2.82e-06	0.000309	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—uterine cancer	2.81e-06	0.000307	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.79e-06	0.000305	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NRAS—uterine cancer	2.77e-06	0.000304	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KRAS—uterine cancer	2.72e-06	0.000298	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—uterine cancer	2.72e-06	0.000297	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNB1—uterine cancer	2.7e-06	0.000295	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.68e-06	0.000293	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PTEN—uterine cancer	2.63e-06	0.000288	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTEN—uterine cancer	2.62e-06	0.000287	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—uterine cancer	2.56e-06	0.000281	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EP300—uterine cancer	2.51e-06	0.000274	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—uterine cancer	2.5e-06	0.000274	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—EP300—uterine cancer	2.5e-06	0.000273	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—uterine cancer	2.48e-06	0.000271	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—uterine cancer	2.42e-06	0.000265	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.39e-06	0.000262	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KRAS—uterine cancer	2.39e-06	0.000261	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—uterine cancer	2.37e-06	0.00026	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NRAS—uterine cancer	2.34e-06	0.000257	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HRAS—uterine cancer	2.31e-06	0.000253	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—uterine cancer	2.27e-06	0.000248	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	2.19e-06	0.00024	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.18e-06	0.000239	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—STK11—uterine cancer	2.17e-06	0.000238	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.17e-06	0.000238	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—uterine cancer	2.12e-06	0.000232	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—uterine cancer	2.04e-06	0.000224	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HRAS—uterine cancer	2.03e-06	0.000222	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KRAS—uterine cancer	2.02e-06	0.000221	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTEN—uterine cancer	2e-06	0.000219	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—EP300—uterine cancer	1.91e-06	0.000209	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	1.85e-06	0.000203	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—uterine cancer	1.85e-06	0.000203	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—uterine cancer	1.85e-06	0.000202	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—uterine cancer	1.79e-06	0.000196	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—uterine cancer	1.79e-06	0.000196	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HRAS—uterine cancer	1.72e-06	0.000188	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTEN—uterine cancer	1.69e-06	0.000185	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.63e-06	0.000179	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—EP300—uterine cancer	1.61e-06	0.000177	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—uterine cancer	1.51e-06	0.000166	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTEN—uterine cancer	1.51e-06	0.000165	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—uterine cancer	1.51e-06	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—EP300—uterine cancer	1.44e-06	0.000158	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—uterine cancer	1.41e-06	0.000154	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTEN—uterine cancer	1.38e-06	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—EP300—uterine cancer	1.31e-06	0.000144	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.19e-06	0.000131	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—uterine cancer	1.15e-06	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.07e-06	0.000117	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—uterine cancer	9.75e-07	0.000107	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—uterine cancer	9.72e-07	0.000106	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTEN—uterine cancer	9.08e-07	9.94e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—uterine cancer	8.71e-07	9.53e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—EP300—uterine cancer	8.66e-07	9.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—uterine cancer	7.94e-07	8.69e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—uterine cancer	6.41e-07	7.01e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—uterine cancer	5.24e-07	5.73e-05	CbGpPWpGaD
